Coriolis Pharma Launches At Spark Life Sciences In Morrisville

By Mary Hecht-Kissell, NCBiotech

Coriolis Pharma, a leading German contract research, development, and manufacturing organization, has announced a significant expansion into the U.S. market with a planned investment of $10.8 million in Morrisville, North Carolina. Over the next five years, the company aims to create 50 new jobs. As part of this expansion, Coriolis will lease approximately 10,000 square feet of state-of-the-art laboratory space at Spark Life Sciences, a cutting-edge facility designed to support scientific advancement. This new location will enable Coriolis to offer a comprehensive suite of services to its clients, which includes drug product development, analytical method development, and biologics manufacturing.

Find out how this move not only strengthens Coriolis Pharma’s global footprint but also contributes to the thriving life sciences ecosystem in North Carolina.